IL-33 Synergizes with TCR and IL-12 Signaling to Promote the Effector Function of CD8+ T Cells

Overview

Journal Eur J Immunol

Specialty Allergy & Immunology

Date 2011 Sep 3

PMID 21887788

Citations 97

Authors

Qianting Yang

Gang Li

Yibei Zhu

Lin Liu

Elizabeth Chen

Heth Turnquist

Xueguang Zhang

Olivera J Finn

Xinchun Chen

Binfeng Lu

Affiliations

Soon will be listed here.

Abstract

The effector functions of CD8(+) T cells are influenced by tissue inflammatory microenvironments. IL-33, a member of the IL-1 family, acts as a danger signal after its release during cell necrosis. The IL-33/ST2 axis has been implicated in various Th2 responses. Its role in CD8(+) T-cell-mediated immune response is, however, not known. Here we find that type 1 cytotoxic T (Tc1) cells cultured in vitro unexpectedly express high levels of the IL-33 receptor ST2. Interestingly, the expression of ST2 in Tc1 cells is dependent on T-bet, a master Th1/Tc1 transcription factor. In addition, IL-33 enhances TCR-triggered IFN-γ production. IL-33 together with IL-12 can stimulate IFN-γ production in Tc1 cells. Moreover, IL-33 synergizes with IL-12 to promote CD8(+) T-cell effector function. The synergistic effect of IL-33 and IL-12 is partly mediated by Gadd45b. Together, these in vitro data establish a novel role of IL-33 in promoting effector type 1 adaptive immune responses.

Citing Articles

Leptin/LPS-treated dendritic cells reduce the expression of genes involved in tumor tissue metastasis and angiogenesis in an animal model of breast cancer.

Basirjafar P, Jafarzadeh A, Salimian J Immunol Res. 2024; 73(1):2.

PMID: 39658676 DOI: 10.1007/s12026-024-09564-8.

The Relationship between HERV, Interleukin, and Transcription Factor Expression in ZIKV Infected versus Uninfected Trophoblastic Cells.

Costa A, Prieto-Oliveira P, Duarte-Barbosa M, Andreata-Santos R, Peter C, Prolo de Brito T Cells. 2024; 13(17.

PMID: 39273061 PMC: 11394337. DOI: 10.3390/cells13171491.

Unveiling the multifaceted antitumor effects of interleukin 33.

Arrizabalaga L, Risson A, Ezcurra-Hualde M, Aranda F, Berraondo P Front Immunol. 2024; 15:1425282.

PMID: 38881897 PMC: 11176530. DOI: 10.3389/fimmu.2024.1425282.

A novel type-2 innate lymphoid cell-based immunotherapy for cancer.

Saranchova I, Xia C, Besoiu S, Finkel P, Ellis S, Kari S Front Immunol. 2024; 15:1317522.

PMID: 38524132 PMC: 10958781. DOI: 10.3389/fimmu.2024.1317522.

IL-33/ST2 Axis: A Potential Therapeutic Target in Neurodegenerative Diseases.

Jia Z, Guo M, Ge X, Chen F, Lei P Biomolecules. 2023; 13(10).

PMID: 37892176 PMC: 10605306. DOI: 10.3390/biom13101494.

References

Baekkevold E, Roussigne M, Yamanaka T, Johansen F, Jahnsen F, Amalric F . Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol. 2003; 163(1):69-79. PMC: 1868188. DOI: 10.1016/S0002-9440(10)63631-0. View

Lu B, Zagouras P, Fischer J, Lu J, Li B, Flavell R . Kinetic analysis of genomewide gene expression reveals molecule circuitries that control T cell activation and Th1/2 differentiation. Proc Natl Acad Sci U S A. 2004; 101(9):3023-8. PMC: 365738. DOI: 10.1073/pnas.0307743100. View

Cruz-Guilloty F, Pipkin M, Djuretic I, Levanon D, Lotem J, Lichtenheld M . Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med. 2009; 206(1):51-9. PMC: 2626671. DOI: 10.1084/jem.20081242. View

Zhou X, Yu S, Zhao D, Harty J, Badovinac V, Xue H . Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity. 2010; 33(2):229-40. PMC: 2928475. DOI: 10.1016/j.immuni.2010.08.002. View

Takemoto N, Intlekofer A, Northrup J, Wherry E, Reiner S . Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol. 2006; 177(11):7515-9. DOI: 10.4049/jimmunol.177.11.7515. View

Liew F, Pitman N, McInnes I . Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010; 10(2):103-10. DOI: 10.1038/nri2692. View

Jones L, Roberts F, Nickdel M, Brombacher F, McKenzie A, Henriquez F . IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol. 2009; 40(2):426-36. DOI: 10.1002/eji.200939705. View

Moussion C, Ortega N, Girard J . The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS One. 2008; 3(10):e3331. PMC: 2556082. DOI: 10.1371/journal.pone.0003331. View

Humphreys N, Xu D, Hepworth M, Liew F, Grencis R . IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol. 2008; 180(4):2443-9. DOI: 10.4049/jimmunol.180.4.2443. View

10.

Pushparaj P, Tay H, Hng S, Pitman N, Xu D, McKenzie A . The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A. 2009; 106(24):9773-8. PMC: 2700978. DOI: 10.1073/pnas.0901206106. View

11.

Xu D, Chan W, Leung B, Huang F, Wheeler R, Piedrafita D . Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 1998; 187(5):787-94. PMC: 2212173. DOI: 10.1084/jem.187.5.787. View

12.

Kallies A, Xin A, Belz G, Nutt S . Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity. 2009; 31(2):283-95. DOI: 10.1016/j.immuni.2009.06.021. View

13.

Wieland C, van der Windt G, Florquin S, McKenzie A, van der Poll T . ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis. Microbes Infect. 2009; 11(4):524-30. DOI: 10.1016/j.micinf.2009.02.007. View

14.

Pearce E, Mullen A, Martins G, Krawczyk C, Hutchins A, Zediak V . Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science. 2003; 302(5647):1041-3. DOI: 10.1126/science.1090148. View

15.

Smithgall M, Comeau M, Yoon B, Kaufman D, Armitage R, Smith D . IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol. 2008; 20(8):1019-30. DOI: 10.1093/intimm/dxn060. View

16.

Guo L, Wei G, Zhu J, Liao W, Leonard W, Zhao K . IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A. 2009; 106(32):13463-8. PMC: 2726336. DOI: 10.1073/pnas.0906988106. View

17.

Shin H, Blackburn S, Intlekofer A, Kao C, Angelosanto J, Reiner S . A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity. 2009; 31(2):309-20. PMC: 2747257. DOI: 10.1016/j.immuni.2009.06.019. View

18.

Lu B, Ferrandino A, Flavell R . Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells. Nat Immunol. 2003; 5(1):38-44. DOI: 10.1038/ni1020. View

19.

Chan W, Pejnovic N, Lee C, Al-Ali N . Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes. J Immunol. 2001; 167(3):1238-44. DOI: 10.4049/jimmunol.167.3.1238. View

20.

Allakhverdi Z, Smith D, Comeau M, Delespesse G . Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol. 2007; 179(4):2051-4. DOI: 10.4049/jimmunol.179.4.2051. View